Target intelligence / Profile preview

Lipid metabolism genes

Molecular classification
Enzyme, Transcription factor, Receptor, Transporter, Other
01

Overview

Genes involved in fat metabolism refers to a comprehensive set of genetic loci that encode the proteins responsible for the synthesis, transport, and breakdown of lipids in human physiology [1]. These genes include enzymes such as HMG-CoA Reductase (HMGCR) and Fatty Acid Synthase (FASN), as well as master transcriptional regulators like the Peroxisome Proliferator-Activated Receptors (PPARs) and Sterol Regulatory Element-Binding Proteins (SREBPs) [2]. The primary biological function of this gene set is to maintain lipid homeostasis, provide energy through beta-oxidation, and synthesize essential components for cellular membranes and signaling molecules [3]. Dysregulation of these genetic pathways is a primary driver of metabolic syndrome, obesity, non-alcoholic fatty liver disease (NAFLD), and atherosclerosis [4]. Therapeutic intervention is highly diverse, involving drugs that inhibit cholesterol synthesis (statins), enhance fatty acid oxidation (fibrates), or reduce fat absorption (orlistat) [5]. Because the term describes a broad biological process involving hundreds of distinct proteins rather than a single receptor or enzyme, it is considered a pathway-level classification rather than a discrete therapeutic target. [1] National Center for Biotechnology Information (NCBI) Genes and Disease; [2] UniProt Consortium; [3] StatPearls: Lipid Metabolism; [4] Nature Reviews Endocrinology: Lipid metabolism in disease; [5] PubChem: Lipid Modulating Agents.

Other names
Fat metabolism genesLipid metabolism pathwayFatty acid metabolism genesAdipogenesis and lipolysis genes
02

Mechanism of action

HMG-CoA reductase inhibition, PPAR activation, Niemann-Pick C1-Like 1 (NPC1L1) inhibition, Gastric and pancreatic lipase inhibition, PCSK9 inhibition

03

Biological functions

Lipid metabolismFatty acid oxidationLipogenesisCholesterol homeostasisEnergy storageSignal transduction
04

Disease associations

ObesityCardiovascular diseaseType 2 diabetesDyslipidemiaNon-alcoholic fatty liver disease (NAFLD)Metabolic syndrome
05

Safety considerations

HepatotoxicityMyopathy and rhabdomyolysisGastrointestinal distressWeight gain (specific to certain PPAR agonists)Increased risk of new-onset diabetes
06

Interacting drugs

Atorvastatin

5 more in the full profile.

07

Biomarkers

Low-density lipoprotein (LDL) cholesterolHigh-density lipoprotein (HDL) cholesterolTriglyceridesApolipoprotein BFree fatty acids

Beyond the preview

Go deeper on Lipid metabolism genes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid metabolism genes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call